Federated Hermes, Inc. Abcam PLC Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.38 - $21.54 $6.38 Million - $7.91 Million	-367,223 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.47 - $22.11 $2.45 Million - $2.94 Million	-132,777 Reduced 26.56%	367,223 $6.99 Million
Q4 2020 Feb 12, 2021	BUY	$18.2 - $22.45 $9.1 Million - $11.2 Million	500,000 New	500,000 $10.8 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.